Gerhard Levy Lecture Series

Levy in Lab.

Gerhard Levy, pioneering researcher and renowned scholar

UB Distinguished Professor Emeritus of Pharmaceutical Sciences Gerhard Levy was a pioneer and leading contributor in the areas of pharmacokinetics and clinical pharmacokinetics.

Levy is considered the originator of the biopharmaceutics field and the “father” of pharmacodynamics.

When Dr. Gerhard Levy retired in 2000 after four decades of service, the UB Department of Pharmaceutical Sciences established the lectureship, as well as a named seminar room, in recognition of the significant contributions Levy made in his fields of study and to honor a beloved friend and esteemed colleague who deftly balanced his love of teaching with robust research.

2020 Gerhard Levy Distinguished Lectureship in Pharmaceutical Sciences

Yuichi Sugiyama, PhD.

Albumin-mediated Hepatic Uptake of Organic Anion Transport Polypeptide 1B (OATP1B) Substrates and its Translational Implications
Speaker: Yuichi Sugiyama, PhD
Tuesday, February 9, 2021, at 4:30 p.m.


Our 2020 Gerhard Levy Distinguished Lectureship will be held virtually.

Please email Corrine Cardy to request the Zoom link.

Dr. Sugiyama received his PhD from the University of Tokyo School of Pharmacy in 1978. He retired from the University of Tokyo in 2012 and has continued his studies as head of the Sugiyama Laboratory at the RIKEN Innovation Center.

Dr. Sugiyama is acknowledged as a world-leader in the fields of physiologically-based pharmacokinetics and membrane transporters. His work on physiologically-based pharmacokinetics has been pivotal for quantitative in vitro – in vivo extrapolation, especially the development of models for the prediction of drug clearance and the magnitude of drug-drug interactions in humans. Further, his studies on membrane transporters, which encompass functional and kinetic characterization, and the impact of genetic variation, have been fundamental to our understanding of the role of transporters in drug disposition.

Dr. Sugiyama is the author of approximately 700 original articles, 70 review articles. Dr. Sugiyama has been the recipient of many awards, including the AAPS Distinguished Pharmaceutical Scientist Award in 2003, PSWC Research Achievement Award in 2007, ISSX Asia Pacific Scientific Achievement Award in 2008, FIP Host-Madsen Gold Medal in 2009, Medal with Purple Ribbon given by Government of Japan in 2010, BB Brodie Award from ASPET in 2012, Rawls-Palmer Progress in Medicine Award from ASCPT in 2014, the RT Williams Distinguished Scientific Achievement Award from ISSX in 2013 and The Order of the Sacred Treasure, Gold Rays with Neck Ribbon by Government of Japan 2020.

In addition to his scientific work, Dr Sugiyama has held leadership positions in several scientific organizations. In particular, he has served as the chairman of board of Pharmaceutical Sciences (BPS) of FIP and Presidents of ISSX and JSSX and strongly promoted worldwide drug metabolism, disposition, transporter research.